Saudi Arabia says OPEC will maintain its current oil production no matter what—until crude hits $40, Breitling Energy' Chris Faulkner said.» Read More
Companies making headlines after the bell Tuesday:
A new Ebola vaccine could be ready to send to West Africa soon, NewLink Genetics' Charles Link says.
Jim Cramer gets some valuable technical advice from the chart experts, and he thinks it could be time to buy this breed of stock.
GT Advanced can start shuttering a plant in Mesa, Arizona, that Apple had helped finance in return for exclusive supply of sapphire.
Herbalife CEO, Michael Johnson, talks about the FTC investigation and Bill Ackman accusations in a recent interview with Los Angeles Magazine.
The German automaker said the two companies would still cooperate on projects.
Corporations are piling on debt, but investors don't seem worried—at least for now—even though such complacency helped drive the financial crisis.
Gold may have seen its lows of the year this month, but it's too soon for gold bulls to declare victory.
The S&P sectors leading the market rebound are the same groups that led the decline: Materials, energy and industrials.
One options trader made a big bet Facebook's run could take a pause.
Art Cashin of UBS Financial Services says oil above $82 is supportive of the market, helping major averages recover from last week's whipsaw action.
Hedge fund titan David Tepper is dipping his toes into the currency waters.
Although stocks rallied on Tuesday, investors couldn’t help but notice some very noticeable losers.
A Georgia woman is pleading with council officials to be allowed to keep her home after it was sold due to a $95 unpaid tax bill.
In her Grammy award winning song Lorde says “ And we'll never be royals. It don't run in our blood.” People in Kansas City would like a word.
Greenwich Wealth Management's Vahan Janjigian said he believes both large-cap names can overcome the problems now plaguing them.
McDonald's is pinning its domestic turnaround hopes in part on a campaign highlighting its food quality. So is it working?
Hedge fund manager Dan Loeb recommended Amgen's stock Tuesday, causing shares to rise on the news.
A big name insurer is warning of possible Ebola-related restrictions on business liability coverage.
Demand for Apple's iPad Mini may be waning as more users gravitate toward bigger—and smaller—devices, according to a Slice Intelligence.